133 related articles for article (PubMed ID: 9253955)
1. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: involvement of angiotensin II and the 5-HT2 receptor activation.
Morán A; Velasco C; Martín ML; San Román L
Eur J Pharmacol; 1997 Jul; 330(2-3):205-11. PubMed ID: 9253955
[TBL] [Abstract][Full Text] [Related]
2. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Fernández MM; Morán A; Martín ML; San Román L
Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
[TBL] [Abstract][Full Text] [Related]
3. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
[TBL] [Abstract][Full Text] [Related]
4. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats.
Morán A; de Urbina AV; Martín ML; Rodríguez-Barbero A; Román LS
Eur J Pharmacol; 2009 Oct; 620(1-3):90-6. PubMed ID: 19699736
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-hydroxytryptamine on neurogenic vasoconstriction in the isolated, autoperfused hindquarters of the rat.
Calama E; Ortíz de Urbina AV; Morán A; Martín ML; San Román L
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):894-900. PubMed ID: 16173953
[TBL] [Abstract][Full Text] [Related]
7. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator and vasoconstrictor responses induced by 5-hydroxytryptamine in the in situ blood autoperfused hindquarters of the anaesthetized rat.
Calama E; Fernández MM; Morán A; Martín ML; San Román L
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):110-6. PubMed ID: 12122496
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):640-7. PubMed ID: 25854421
[TBL] [Abstract][Full Text] [Related]
11. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.
Centurión D; Ortiz MI; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):983-90. PubMed ID: 11226128
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
Villalón CM; Ramírez-San Juan E; Castillo C; Castillo E; López-Muñoz FJ; Terrón JA
Br J Pharmacol; 1995 Nov; 116(6):2778-84. PubMed ID: 8591004
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of responses to sympathetic nerve stimulation and vasoconstrictor agents by SK&F 103829 in the feline mesenteric circulation.
Taylor EM; Kaumann AJ
Br J Pharmacol; 1994 Jan; 111(1):264-70. PubMed ID: 8012704
[TBL] [Abstract][Full Text] [Related]
14. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.
Choppin A; O'Connor SE
Br J Pharmacol; 1995 Jan; 114(2):309-14. PubMed ID: 7881730
[TBL] [Abstract][Full Text] [Related]
15. Effects of oxyhemoglobin on vasoconstriction in response to 5-hydroxytryptamine in isolated, perfused canine basilar arteries.
Orz YI; Tsuji T; Aoki T; Yen Y; Chiba S; Kobayashi S
Neurosurgery; 1998 Nov; 43(5):1176-84. PubMed ID: 9802861
[TBL] [Abstract][Full Text] [Related]
16. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
Barrett RJ; Droppleman DA
Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed.
Rodat-Despoix L; Crevel H; Marthan R; Savineau JP; Guibert C
J Vasc Res; 2008; 45(3):181-92. PubMed ID: 18025789
[TBL] [Abstract][Full Text] [Related]
18. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.
Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V
J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791
[TBL] [Abstract][Full Text] [Related]
19. m-CPP, a 5-HT2C receptor agonist that modifies the perfusion pressure of the hindquarter vascular bed of anesthetized rat.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2005 Feb; 73(2):70-5. PubMed ID: 15452415
[TBL] [Abstract][Full Text] [Related]
20. The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.
Centurión D; Ortiz MI; Saxena PR; Villalón CM
Br J Pharmacol; 2002 Mar; 135(6):1531-9. PubMed ID: 11906967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]